ArticleCurrent oncology (Toronto, Ont.)2025

Real-World Clinical Outcomes with First-Line Systemic Treatment and Avelumab Maintenance in US Patients with Locally Advanced or Metastatic Urothelial Carcinoma: The SPEAR Bladder-II Study.

Sneha Sura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.